Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Lacey, Discovery Labs To Manufacture Afectair | Contract Pharma

What are you searching for?

Sign in
Breaking News

Lacey, Discovery Labs To Manufacture Afectair

Inhaled therapy panel to be on market in late 2012

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Discovery Laboratories has entered into a definitive agreement with Lacey Manufacturing, a unit of Precision Engineered Products, to manufacture and supply product for the commercial launch of Afectair. Discovery Labs anticipates that the drug will be commercially available in late 2012.

“This manufacturing and supply agreement with Lacey is an important operational milestone that takes us one step closer to the commercial introduction of Afectair later this year,” said Thomas F. Miller, senior vice president and chief operating Officer of Discovery Labs. “We believe Lacey is the right manufacturing partner for Discovery Labs as they have substantial experience with medical device injection molding and a proven track record of achieving program objectives with industry-leading medical technology companies.”

Afectair is a series of ventilator circuit/patient interface connectors and related componentry that simplifies the delivery of inhaled therapies to critical care patients requiring ventilatory support. Discovery Labs is pursuing a European Conformity (CE) marking for commercialization of the initial Afectair products in the EU and can potentially launch in late 2012.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics